Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to accomplish so could be grounds for compensation. Our lawyers are operating hard to get these hurt by the drug the compensation they may be entitled to.













image class="left" url="https://images57.fotki.com/v496/photos/6/3677706/13843352/Xareltolawsuits-vi.jpg"Although bleeding can be a frequent complication connected with anticoagulants, it has been alleged that Xarelto is more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, individuals may be at danger for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.













In case you or possibly a loved one suffered a critical bleeding occasion after taking Xarelto, you may have legal recourse. For far more data, make contact with us right now to possess your case reviewed, free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral expenses. Furthermore, they're in search of punitive damages, that are usually awarded to punish the defendant and deter other businesses from acting similarly.






Why Are Lawsuits Getting Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






xarelto pharmaceutical company is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













image class="left" url="https://images57.fotki.com/v496/photos/6/3677706/13843352/Xareltolawsuits-vi.jpg"Visit this page for much more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki